Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus, With or Without Cardiovascular Disease: A Systematic Review and Meta-Analysis of 10,013 Patients.

IF 2.9 4区医学 Q2 PHARMACOLOGY & PHARMACY

American journal of therapeutics Pub Date : 2024-11-20 DOI:10.1097/MJT.0000000000001828

Adarsh Raja, Asfia Qammar, Sumet Kumar, Hafsah Alim Ur Rahman, Sandesh Raja, Mukesh Kumar

引用次数: 0

查看原文本刊更多论文

西马鲁肽治疗伴或不伴心血管疾病的慢性肾病和2型糖尿病患者的安全性和有效性：10013例患者的系统评价和荟萃分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of therapeutics PHARMACOLOGY & PHARMACY-

CiteScore

5.50

自引率

9.50%

发文量

142

审稿时长

6-12 weeks

期刊介绍： American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.